Sorted By:

Relevance


ICYMI: Ubl weighs in on how fair trade protects US biopharmaceutical innovation

PhRMA  |  Blog Post

These barriers have demonstrable impact: they limit the U.S.’ ability to invest in research and development here at home, thereby threatening U.S. jobs and development of new medicines for the world’s patients. 
http://catalyst.phrma.org/icymi-ubl-weighs-in-on-how-fair-trade-protects-us-biopharmaceutical-innovation

Burden 2015 - Diabetes

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/burden-2015-diabetes

Hospitals and Grantees Have Different Requirements for Use of 340B

Chartpack  |  From Our Network

Grantees eligible for 340B on the basis of a federal grant use revenue from 340B and other sources to help vulnerable patients.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/hospitals-and-grantees-have-different-requirements-for-use-of-340b

Medicare Part D’s six protected classes

PhRMA  |  Blog Post

This week’s Conversations forum asks leading health experts: Why are Medicare Part D’s six protected classes important for patients?
http://catalyst.phrma.org/medicare-part-d-six-protected-classes

10 Things You Should Know About Medicine Spending and Costs

PhRMA  |  Graphic

Many patients struggle to access the medicine they need and have important questions about their costs. 
https://www.phrma.org/graphic/10-things-you-should-know-about-medicine-spending-and-costs

New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of Tomorrow

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
https://www.phrma.org/press-release/new-report-alzheimer-s-research-setbacks-critical-for-breakthroughs-of-tomorrow

Burden 2015 - Oncology

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/burden-2015-oncology

I’m Not Average – Matt Ellefson May Have Cancer, But Cancer Doesn’t Have Him

PhRMA  |  Video

In this video he shares his inspirational story of defying the odds and managing his disease to lead a happy and active life because of the progress made in cancer research.
https://www.phrma.org/video/i-m-not-average-matt-ellefson-may-have-cancer-but-cancer-doesn-t-have-him

ICYMI – 3 new reports show dramatic slowdown in medicine spending growth

PhRMA  |  Blog Post

Unlike care received at an in-network hospital or physician’s office, a patient’s cost-sharing for medicines, including payments for care received prior to meeting a deductible or from a co-insurance, is typically based on the list price of a medicine, not the net prices after rebates and discounts are factored in.
http://catalyst.phrma.org/icymi-3-new-reports-show-dramatic-slowdown-in-medicine-spending-growth

A voice for patients

PhRMA  |  Blog Post

For me, and countless others who work in the biopharmaceutical industry, we see the great promise of the work that we do each and every day to address the remaining unmet medical needs for patients.
http://catalyst.phrma.org/a-voice-for-patients

PhRMA Applauds President Obama For Highlighting Importance of Innovation

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.
https://www.phrma.org/press-release/phrma-applauds-president-obama-for-highlighting-importance-of-innovation

Ask About Adherence: How poorly managed blood pressure is placing older Americans at risk for heart disease and stroke

PhRMA  |  Blog Post

The Centers for Medicare & Medicaid Services has included medication adherence quality measures in the Parts C and D Star Ratings Program to support improved adherence to certain classes of medications, including those used to treat high blood pressure.
http://catalyst.phrma.org/ask-about-adherence-how-poorly-managed-blood-pressure-is-placing-older-americans-at-risk-for-heart-disease-and-stroke

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

Changes to this benefit could result in limited choices or forced changes in prescribed treatment and put patients at unnecessary risk.
http://catalyst.phrma.org/medicare-monday-who-qualifies-for-part-d-extra-help

The 20-year journey yielding a new weapon against cancer

PhRMA  |  Video


https://www.phrma.org

Getting What You Pay for in the ACA

Access Better Coverage  |  From Our Network

The Medicare Part D prescription drug program has such a feature, and it's proven hugely helpful to seniors.
http://www.accessbettercoverage.org/social-news/getting-what-you-pay-for-in-the-aca

Fact Check Friday: The truth about drug importation and patient safety

PhRMA  |  Blog Post

Get the facts about drug importation here.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-drug-importation-and-patient-safety

The Dangers of Drug Importation: Counterfeit Cancer Drugs

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/the-dangers-of-drug-importation-counterfeit-cancer-drugs

Biopharma leads sustained economic growth driven by IP-intensive industries

PhRMA  |  Blog Post

As the study demonstrates, IP-intensive industries, including the biopharmaceutical industry, help drive sustained economic growth, high-paying jobs, and investments in research & development.
http://catalyst.phrma.org/biopharma-leads-sustained-economic-growth-driven-by-ip-intensive-industries

How patients with hypertension save with Medicare Part D

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/how-patients-with-hypertension-save-with-medicare-part-d

More Medicines in Development for Older Americans Following Part D Implementation in 2006

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/more-medicines-in-development-for-older-americans-following-part-d-implementation-in-2006

Access to Services Like Prescription Medicines Is More Expensive for Patients with Exchange Coverage

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/access-to-services-like-prescription-medicines-is-more-expensive-for-patients-with-exchange-coverage

40% or More Coinsurance for Medicines on Health Insurance Exchange Plans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/40-or-more-coinsurance-for-medicines-on-health-insurance-exchange-plans

Medicines in Development for Osteoporosis 2016 Report

PhRMA  |  Report

Today, biopharmaceutical research companies are developing nine medicines for the treatment of osteoporosis, all of which are in clinical trials or undergoing regulatory review by the U.S.
https://www.phrma.org/report/medicines-in-development-for-osteoporosis-2016-report

The Next Big Debate in Health Care

Access Better Coverage  |  From Our Network

They can also change the relationship between patients and health-care providers by focusing interactions more on the price of health services, though patients often have trouble comparison shopping for health care, even when pricing tools are available.
http://www.accessbettercoverage.org/social-news/the-next-big-debate-in-health-care

Medicare Part D: Reducing Depressive Symptoms Among Seniors

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-part-d-reducing-depressive-symptoms-among-seniors

You have reviewed the first 325 results out of 2561. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next